UNAIDS estimates that more than 37 million adults and 2 million children are infected with HIV worldwide. The AIDS epidemic has hit the hardest in sub-Saharan Africa, where 75 percent of the women ages 15 to 24 are infected.
Closer to home, 40,000 people per year in the U.S. are infected, more than half of whom are African-American women. The latter group by itself accounts for 72 percent of all new HIV diagnoses in women.
In the face of these overwhelming statistics, what can be done? Some corporations are making a difference with contributions to charities supporting the cause and helping in other ways.
For example, Roche, a pharmaceutical company that developed the HIV protease inhibitors Invirase and Viracept, has not filed any patents for its medicines – including those for HIV/AIDS – in the least-developed nations and sub-Saharan Africa. This means that these countries, which are devastated by the epidemic, can manufacture and sell cheap, generic versions of the drugs without waiting for the patents to expire.
The company also is dedicated to increasing awareness of the illnesses.
“Roche is committed to driving social...
To view and download this full PLR article, you must be logged in. Registration is completely free. Once you create your account, you will be able to browse, search & downlod from our PLR articles database of over "1,57,897+" on 1,000's of niches and 200+ categories without paying a penny. Click here to signup...
